Drug Trial Radar · NCT03789552
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
Last checked: Nov 19, 2026Latest source record: Apr 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
765
Planned (sponsor's estimate)
Start
Aug 1, 2019
Primary completion
Dec 2026
Study completion Mar 2027
Sponsor
- Lead sponsor
- Tasly Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 28, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, double-blind, randomized, placebo-controlled, parallel-group phase 3 clinical study to confirm the safety and efficacy of T89 in patients with stable angina pectoris, with an extended open-label period to evaluate the long-term safety of T89. This study includes three main periods: the first study period is a 3-week single-blind qualifying run-in period to screen eligible stable angina patients by exercise tolerance test (ETT). The second study period is a 8-week double-blind treatment period to evaluate the efficacy and safety of T89 in patients with stable angina by ETT. And, the last study period is a 44-week open-label period to observe long-term use safety of T89.
Conditions
- Chronic Stable Angina Pectoris
Interventions
T89 capsuleDrug
T89 capsules (75mg)
Placebo capsuleDrug
Placebo capsules (0mg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in symptom-limited total exercise duration (TED) at trough drug levels on standard Bruce protocol from baseline to Day 57Time frame: Day 57 (post drug administration from randomization)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Southwest Florida Research LLC
Naples, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.